| P2093 | author name string | E R Pfefferkorn | |
| | S E Borotz | |
| P2860 | cites work | Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins | Q54645205 |
| | Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells | Q68537900 |
| | The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice | Q69474548 |
| | DNA circles with cruciforms from Isospora (Toxoplasma) gondii | Q71269913 |
| | Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics | Q72714851 |
| | In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii | Q28321674 |
| | Electron microscope studies of reproducing and interkinetic Toxoplasma. | Q30991982 |
| | Assessment of therapy for toxoplasma encephalitis. The TE Study Group | Q33454020 |
| | Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii | Q33960170 |
| | Origins of Prokaryotes, Eukaryotes, Mitochondria, and Chloroplasts | Q34102135 |
| | Effect of clindamycin on acute and chronic toxoplasmosis in mice | Q34910401 |
| | Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity | Q35088834 |
| | Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes ofEscherichia coli | Q35284526 |
| | Clindamycin in a murine model of toxoplasmic encephalitis | Q35538321 |
| | Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant | Q35836436 |
| | Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay | Q36753766 |
| | Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon. | Q37081863 |
| | Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. | Q39123475 |
| | Specific Labeling of IntracellularToxoplasma gondiiwith Uracil* | Q39169495 |
| | Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression--a review | Q39849531 |
| | Inhibition of Toxoplasma gondii protein synthesis by azithromycin | Q39866456 |
| | Quantitative Studies of the Mutagenesis of Toxoplasma gondii | Q39893989 |
| | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group | Q40738767 |
| | Toxoplasma gondii: Isolation and preliminary characterization of temperature-sensitive mutants | Q41790457 |
| | Clindamycin for the treatment of falciparum malaria in Sudan | Q41916492 |
| | Clindamycin Uptake by Human Neutrophils | Q42243051 |
| | Successful chemotherapy of transfusion babesiosis | Q47957704 |
| | Have malaria parasites three genomes? | Q47996291 |
| | Identification of a single base change in ribosomal RNA leading to erythromycin resistance | Q54271892 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Toxoplasma gondii | Q131003 |
| | azithromycin | Q165399 |
| | clindamycin | Q422273 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 31-37 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin | |
| P478 | volume | 38 | |